Karyopharm Therapeutics Inc.KPTINASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-154.93%
↓ 246% below average
Average (9y)
-44.77%
Historical baseline
Range
High:-14.40%
Low:-154.93%
CAGR
+25.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -154.93% | -65.1% |
| 2023 | -93.81% | -74.5% |
| 2022 | -53.77% | -130.1% |
| 2021 | -23.36% | -62.3% |
| 2020 | -14.40% | +10.6% |
| 2019 | -16.10% | +47.0% |
| 2018 | -30.37% | -81.2% |
| 2017 | -16.76% | +30.1% |
| 2016 | -23.97% | -18.4% |
| 2015 | -20.24% | - |